ACUTE PACING THRESHOLD ELEVATION DURING SIMULTANEOUS L0EADLESS PACEMAKER IMPLANTATION AND ATRIOVENTRICULAR NODE ABLATION

2021 ◽  
Vol 37 (10) ◽  
pp. S48
Author(s):  
N Dognin ◽  
H Racine ◽  
B Plourde ◽  
F Molin ◽  
G O'Hara ◽  
...  
2018 ◽  
Vol 41 (11) ◽  
pp. 1484-1490 ◽  
Author(s):  
José Luis Martínez-Sande ◽  
Moisés Rodríguez-Mañero ◽  
Javier García-Seara ◽  
Ramón Lago ◽  
Laila González-Melchor ◽  
...  

EP Europace ◽  
1999 ◽  
Vol 1 (1) ◽  
pp. 30-34 ◽  
Author(s):  
J. M. McComb ◽  
G. M. Gribbin

Abstract Aims This study examined the factors associated with the development of chronic (or permanent) atrial fibrillation (AF) in patients who had undergone atrioventricular (AV) node ablation with permanent pacing because of paroxysmal AF. Methods A retrospective review of case notes of all 65 consecutive patients identified as having had paroxysmal atrial arrhythmias, AV node ablation and permanent pacemaker implantation was performed. Atrial rhythm was established from all pacing records and from the surface ECG. Treatment with anti-arrhythmic drugs and with warfarin was recorded. A multivariate analysis was undertaken, using atrial rhythm on final ECG and chronic AF as outcome measures. Results During a mean follow-up of 30 months, 42% of patients with paroxysmal AF had developed chronic AF. Multivariate analysis showed that increasing age, history of electrical cardioversion and VVI pacing all contributed to the development of chronic AF. 25/62 patients were taking warfarin, and four had had strokes (2·5%/year). Conclusions The majority of patients with paroxysmal atrial arrhythmias treated with AV node ablation and pacing develop chronic AF eventually. Stroke remains a risk, particularly in those who develop chronic AF.


EP Europace ◽  
2008 ◽  
Vol 10 (4) ◽  
pp. 412-418 ◽  
Author(s):  
E. S. Tan ◽  
M. Rienstra ◽  
A. C.P. Wiesfeld ◽  
B. A. Schoonderwoerd ◽  
H. H.F. Hobbel ◽  
...  

2019 ◽  
Vol 13 (1) ◽  
pp. 21-29 ◽  
Author(s):  
Somsupha Kanjanauthai ◽  
Kabir Bhasin ◽  
Luigi Pirelli ◽  
Chad A Kliger ◽  

Transcatheter aortic valve replacement (TAVR) has been established as a therapeutic option for patients with severe symptomatic aortic stenosis who are of intermediate or higher surgical risk. Several periprocedural complications are reduced with newer transcatheter heart valve generations; however, conduction abnormalities and the need for permanent pacemaker implantation have remained unchanged and are the most frequent TAVR complications. The close relationship of the atrioventricular node and left bundle branch to the subaortic region explains these potential conduction abnormalities. This article highlights conduction abnormalities after TAVR with a focus on basic conduction system anatomy in relation to the aortic valve, the mechanism, incidence, predisposing factors for occurrence, impact on mortality and finally, proposed treatment algorithms for management.


Sign in / Sign up

Export Citation Format

Share Document